We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$72.6B
AUM Growth
+$7.53B
Cap. Flow
+$3.73B
Cap. Flow %
5.13%
Top 10 Hldgs %
9.55%
Holding
3,940
New
507
Increased
1,441
Reduced
1,273
Closed
394

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$434M
2
NFLX icon
Netflix
NFLX
+$301M
3
BABA icon
Alibaba
BABA
+$245M
4
VZ icon
Verizon
VZ
+$235M
5
TSLA icon
Tesla
TSLA
+$230M

Sector Composition

Rank Sector Weight
1 Technology 13.27%
2 Healthcare 11.28%
3 Consumer Discretionary 8.99%
4 Communication Services 8.03%
5 Industrials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBH icon
2451
Prestige Consumer Healthcare
PBH
$2.41B
$1.16M ﹤0.01%
+26,004
New +$1.18M
OMED
2452
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.15M ﹤0.01%
280,930
+122,914
+78% +$535K
NPKI
2453
NPK International
NPKI
$1.18B
$1.15M ﹤0.01%
133,501
+42,222
+46% +$382K
KE
2454
Kimball Electronics
KE
$584M
$1.15M ﹤0.01%
62,777
+3,867
+7% +$79.8K
VIAB
2455
CALL
DELISTED
Viacom Inc. Class B
VIAB
$1.14M ﹤0.01%
37,100
-10,400
-22% -$282K
ANDV
2456
CALL
DELISTED
Andeavor
ANDV
$1.14M ﹤0.01%
10,000
PVG
2457
CALL
DELISTED
PRETIUM RESOURCES INC.
PVG
$1.14M ﹤0.01%
100,000
CAR icon
2458
Avis
CAR
$5.67B
$1.14M ﹤0.01%
25,963
+6,742
+35% +$268K
HSY icon
2459
CALL
Hershey
HSY
$36.1B
$1.14M ﹤0.01%
10,000
LYTS icon
2460
LSI Industries
LYTS
$839M
$1.14M ﹤0.01%
164,903
+39,563
+32% +$267K
XYL icon
2461
Xylem
XYL
$28.6B
$1.13M ﹤0.01%
16,596
-44,854
-73% -$2.98M
GHM icon
2462
Graham Corp
GHM
$1.16B
$1.13M ﹤0.01%
53,970
-10,455
-16% -$212K
UMC icon
2463
United Microelectronic
UMC
$47B
$1.13M ﹤0.01%
471,854
+59,589
+14% +$152K
EW icon
2464
CALL
Edwards Lifesciences
EW
$48B
$1.13M ﹤0.01%
30,000
RGLD icon
2465
CALL
Royal Gold
RGLD
$17.1B
$1.13M ﹤0.01%
13,700
-1,400
-9% -$120K
CASY icon
2466
PUT
Casey's General Stores
CASY
$31.8B
$1.12M ﹤0.01%
10,000
DY icon
2467
CALL
Dycom Industries
DY
$12.3B
$1.11M ﹤0.01%
10,000
JAX
2468
DELISTED
J. Alexander's Holdings, Inc.
JAX
$1.11M ﹤0.01%
114,858
-50,326
-30% -$523K
INO icon
2469
Inovio Pharmaceuticals
INO
$81M
$1.11M ﹤0.01%
22,458
-26,534
-54% -$1.64M
FCB
2470
DELISTED
FCB Financial Holdings, Inc.
FCB
$1.11M ﹤0.01%
21,842
-12,410
-36% -$609K
TGH
2471
DELISTED
Textainer Group Holdings limited
TGH
$1.11M ﹤0.01%
51,550
+4,951
+11% +$102K
CIO
2472
DELISTED
City Office REIT
CIO
$1.11M ﹤0.01%
+85,078
New +$1.12M
DIN icon
2473
PUT
Dine Brands
DIN
$441M
$1.11M ﹤0.01%
21,800
-61,500
-74% -$2.87M
ASCMA
2474
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$1.1M ﹤0.01%
96,214
+5,157
+6% +$62K
MGM icon
2475
PUT
MGM Resorts International
MGM
$11.8B
$1.1M ﹤0.01%
+33,000
New +$1.06M

Similar funds

D.E. Shaw & Co's Q4 2017 Portfolio in Review

As of Q4 2017, D.E. Shaw & Co held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

D.E. Shaw & Co deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $434M trimmed.

  • D.E. Shaw & Co's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
  • D.E. Shaw & Co added most to GE Aerospace in Q4 2017, an estimated $570M increase.
  • D.E. Shaw & Co's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
  • D.E. Shaw & Co fully exited Tesla in Q4 2017, selling an estimated $230M.
  • D.E. Shaw & Co's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
  • D.E. Shaw & Co opened 507 new positions and closed 394 in Q4 2017.
  • D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $72.6B.

Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.